US2007128678A1PendingUtilityA1

Pknb kinase and pstp phosphatase and methods of identifying inhibitory substances

Assignee: PASTEUR INSTITUTPriority: Jul 18, 2003Filed: Jul 19, 2004Published: Jun 7, 2007
Est. expiryJul 18, 2023(expired)· nominal 20-yr term from priority
C12Q 1/485G01N 2333/35C12Q 1/42G01N 2333/912G01N 2500/10C12Q 1/18
55
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The present invention relates to a pknB kinase and a pstP phosphatase as well as their use for identifying antibacterial substances.

Claims

exact text as granted — not AI-modified
1 . A method for identifying a substance which modulates the activity of a pknB protein kinase, comprising: 
 contacting a recombinant bacterial cell with the substance, wherein the recombinant bacterial cell expresses the pknB protein kinase, and wherein the pknB protein kinase comprises the amino acid sequence of SEQ ID NO: 3 or an amino acid sequence that is at least 70% identical to SEQ ID NO: 3 and has protein kinase activity;    measuring the pknB protein kinase activity from said bacterial cell; and    comparing the pknB protein kinase activity from the recombinant bacterial cell contacted with the substance to a bacterial cell which has not been contacted with the substance, wherein a change in protein kinase activity from the recombinant bacterial cell contacted with the substance relative to a bacterial cell which has not been contacted with the substance indicates that the substance modulates the activity of pknB protein kinase.    
     
     
         2 . The method of  claim 1 , wherein the pknB protein kinase comprises the amino acid sequence of SEQ ID NO: 3.  
     
     
         3 . The method of  claim 1 , wherein the pknB protein kinase comprises an amino acid sequence that is at least 70% identical to SEQ ID NO: 3 and has protein linase activity.  
     
     
         4 . The method of  claim 3 , wherein the pknB comprises an amino acid sequence that is at least 80% identical to SEQ ID NO: 3 and has protein kinase activity.  
     
     
         5 . The method of  claim 3 , wherein the pknB comprises an amino acid sequence that is at least 90% identical to SEQ ID NO: 3 and has protein kinase activity.  
     
     
         6 . A method for identifying a substance which modulates the activity of a pstP2 phosphatase, comprising: 
 contacting a recombinant bacterial cell with the substance, wherein the recombinant bacterial cell expresses the pstP2 phosphatase, and wherein the pstP2 phosphatase comprises the amino acid sequence of SEQ ID NO: 1 or an amino acid sequence that is at least 70% identical to SEQ ID NO: 1 and has phosphatase activity;    measuring the pstP2 phosphatase activity from the recombinant bacterial cell; and    comparing the pstP2 phosphatase activity from the recombinant bacterial cell contacted with the substance to a bacterial cell which has not been contacted with the substance, wherein a change in phosphatase activity from the recombinant bacterial cell contacted with the substance relative to a bacterial cell which has not been contacted with the substance indicates that the substance modulates the activity of pstP2 phosphatase.    
     
     
         7 . The method of  claim 6 , wherein the pstP2 phosphatase comprises the amino acid sequence of SEQ ID NO: 1.  
     
     
         8 . The method of  claim 6 , wherein the pstP2 phosphatase comprises an amino acid sequence that is at least 70% identical to SEQ ID NO: 1 and has phosphatase activity.  
     
     
         9 . The method of  claim 6 , wherein the pstP2 phosphatase comprises an amino acid sequence that is at least 80% identical to SEQ ID NO: 1 and has phosphatase activity.  
     
     
         10 . The method of  claim 6 , wherein the pknB comprises an amino acid sequence that is at least 90% identical to SEQ ID NO: 1 and has phosphatase activity.  
     
     
         11 . A method of identifying an antibacterial substance, comprising: 
 identifying a substance according to  claims 1  to  5 ;    contacting a bacterial cell with the substance; and    comparing the growth, the survival or both of the bacterial cell contacted with the substance to a bacterial cell that has not been contacted with the substance, wherein a reduction in the growth, survival or both of the bacterial cell is indicative that the substance is an antibacterial substance.    
     
     
         12 . A method of identifying an antibacterial substance, comprising: 
 identifying a substance according to  claims 6  to  10 ; and    contacting a bacterial cell with the substance;    comparing the growth, the survival or both of the bacterial cell contacted with the substance to a bacterial cell that has not been contacted with the substance, wherein a reduction in the growth, survival or both of the bacterial cell is indicative that the substance is an antibacterial substance.    
     
     
         13 . A method for the preparation of a substance having antimicrobial activity, comprising: 
 identifying a substance according to  claims 1  to  5 ; and    synthesizing the substance.    
     
     
         14 . A method for the preparation of a substance having antimicrobial activity, comprising: 
 identifying a substance according to  claims 6  to  10 ; and    synthesizing the substance.

Join the waitlist — get patent alerts

Track US2007128678A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.